Navigation Links
Bentley Late Breaking Abstract Accepted for Poster Presentation at,American Diabetes Association Scientific Sessions

ucted over 1,500 Phase I through III clinical trials, primarily in targeted endocrine populations. Currently work is underway on construction of a new 80,000sq. ft. Phase I unit. For more information visit www.dgdclinic.com and www.dgdresearch.com.

Bentley Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on advanced drug delivery technologies and generic pharmaceutical products. Bentley's proprietary drug delivery technologies enhance the absorption of pharmaceutical compounds across various membranes. Bentley manufactures and markets a growing portfolio of generic and branded generic pharmaceuticals in Europe for the treatment of cardiovascular, gastrointestinal, infectious and central nervous system diseases through its subsidiaries -- Laboratorios Belmac, Laboratorios Davur, Laboratorios Rimafar and Bentley Pharmaceuticals Ireland. Bentley also manufactures and markets active pharmaceutical ingredients through its subsidiary, Bentley API.

Additional information regarding Bentley Pharmaceuticals may be obtained through Bentley's web site at www.bentleypharm.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward looking statements, including without limitation, statements regarding plans for the announcement of interim results of clinical trials of Bentley's intranasal insulin product candidate. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from future results expressed or implied by such statements. Factors that may cause such differences include, but are not limited to, risks associated with the efficacy and safety of Bentley's intranasal insulin product candidate and its drug delivery technology, risks associated with international clinical trials, and other risks detailed under Item 1A "Risk Factors" in Bentley's most recent Annual Report on Form 10-K and its subseq
'"/>




Page: 1 2 3

Related medicine technology :

1. Bentley Reports Positive Results with Nasulin Intranasal Insulin Spray at the American Diabetes Association Meeting
2. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
3. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
4. Pilot Phase 3 Results of NovaCardias KW-3902 for Acute Congestive Heart Failure Presented at Late-Breaking Session of Heart Failure Congress 2007
5. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
6. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
7. Everest Data on Short- and Long-Term Use of Otsukas Investigational Novel Treatment, Tolvaptan, Published in Journal of the American Medical Association and Featured in ACCs Late Breaking Clinical Trials
8. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
9. Savient Pharmaceuticals Announces Acceptance of Two Gout-Related Abstracts for Poster Presentation at the European League Against Rheumatism (EULAR) 2007 Annual Congress
10. OXiGENE Abstracts Published in ASCO Program
11. Six Abstracts Featuring Exelixis Compounds Accepted At ASCO Conference
Post Your Comments:
(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... strategic assessment of the competitive environment ... priority management responsibilities, the task crucial ... Timely and factual competitive intelligence is ...
(Date:12/15/2009)... Israel, December 15 EnzySurge Ltd.,(EnzySurge), ... advanced chronic,wound management market, announced today that ... and Drug Administration (FDA) to market its ... also cleared,DermaSept, an Over-the-Counter version of the ... EnzySurge is the developer of the DermaStream(R) ...
(Date:12/15/2009)... today,s regular meeting of the board of directors of ... board declared a regular quarterly dividend of 31 cents ... record at the close of business on February 10, ... The Lubrizol Corporation (NYSE: LZ ) is ... technologies that improve the quality and performance of our ...
Breaking Medicine Technology:Reportlinker Adds Top Ten World's Leading Orthopedics Companies 2Reportlinker Adds Top Ten World's Leading Orthopedics Companies 3EnzySurge Receives FDA Approval for SilverStream(TM) Innovative Wound Management Solution 2Lubrizol Declares Dividend 2MEDRAD Demonstrates PACS Injection Record Integration at RSNA 2009 6738 1MEDRAD Demonstrates PACS Injection Record Integration at RSNA 2009 6738 2MEDRAD Demonstrates PACS Injection Record Integration at RSNA 2009 6738 3Researchers identify gene that spurs deadly brain cancer 62553 1Researchers identify gene that spurs deadly brain cancer 62553 2Researchers identify gene that spurs deadly brain cancer 62553 3New Hepatitis C Treatment Shows Promise 62550 1New Hepatitis C Treatment Shows Promise 62550 2New Hepatitis C Treatment Shows Promise 62550 3
(Date:12/15/2009)... of 30 Individuals Charged in Miami, Detroit and ... Billing to Medicare ,, WASHINGTON, Dec. ... in three cities for their alleged roles in ... false Medicare claims as part of the continuing ... of Health and Human Services (HHS) Secretary Kathleen ...
(Date:12/15/2009)... Children taught to recognize symptoms will call for help, ... Stroke-related disability could be reduced by teaching children how ... to call 911 immediately, a new study shows. , ... stroke symptoms can limit the extent of brain damage ... and Defeating Stroke (KIDS) project included 515 sixth graders ...
(Date:12/15/2009)... decide benefits of imaging outweigh the risks , , TUESDAY, ... a serious risk to people with heart pacemakers, researchers ... pacemakers to a simulated MRI magnetic field and then ... the pacemaker lead, where it would touch the interior ... magnetic pulses caused certain pacemakers to deliver a drastically ...
(Date:12/15/2009)... Health Technologies, Inc. (OTC Bulletin Board: VHGI) confirmed ... subsidiary of VHGI) has appointed two key industry ... with bringing the Treasure Gulch and Zero Gold ... Additionally, the company is informing interested shareholders and ... Live Investor Town Hall Meeting so that investors ...
(Date:12/15/2009)... Conn., Dec. 15 Aon Consulting, ... Aon Corporation (NYSE: AON ), ... firm as senior vice president with the ... the national Pharmacy Practice. ,, (Logo: ... new role, Zeitel will work under the ...
Breaking Medicine News(10 mins):Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 2Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 3Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 4Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 5Health News:Boosting Kids' Stroke IQ May Save Lives 2Health News:Patients With Pacemakers Should Avoid MRI Scans 2Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 2Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 3Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 4Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 5Health News:Aon Consulting Adds Senior Vice President to National Pharmacy Practice 2Health News:Aon Consulting Adds Senior Vice President to National Pharmacy Practice 3Health News:Aon Consulting Adds Senior Vice President to National Pharmacy Practice 4
... ISTA,Pharmaceuticals, Inc. (Nasdaq: ISTA ), today ... United States Attorney,s Office in Buffalo requesting the,production ... to Xibrom(TM) (bromfenac sodium ophthalmic solution),0.09%., It ... applicable U.S. and,foreign laws, rules and regulations of ...
... BOSTON, Mass. (April 10, 2008)Researchers at Harvard Pilgrim Health ... Department of Public Health have created and tested a ... to help clinicians detect contagious illness and automatically report ... called Electronic Medical Record Support for Public Health, or ...
... 9 Law Offices of Howard G. Smith,announces ... Co., Inc.,("Merck" or the "Company")(NYSE: MRK ) ... (the "Plan") imprudently invested in,Merck stock and whether ... Plan,s participants in violation of the Employee Retirement,Income ...
... HAE:TSX, MONTREAL, April 9 /PRNewswire-FirstCall/ - ... bio-therapeutics company developing,high-value human plasma-derived protein products ... Special Meeting of Shareholders held this,afternoon., ... in Adhesion Prevention, Haemacure presented the ...
... Will Follow 60,000 Women for 5 Years, ... aged 55,years and older have enrolled in a ... of osteoporosis across the globe. Launch of the,Global ... announced,today at ECCEO 8 (Eighth European Congress on ...
... and Medicaid Services (CMS) mandated that healthcare, providers ... to preventable ... April 9 RF Technologies(R) announces,that it is partnering ... complying with new Medicare regulations that go into effect,October ...
Other Medicine News:Health News:ISTA Pharmaceuticals Announces Receipt of Subpoena Relating to Promotional Practices for XIBROM(TM) 2Health News:ISTA Pharmaceuticals Announces Receipt of Subpoena Relating to Promotional Practices for XIBROM(TM) 3Health News:Researchers pilot new electronic system for infectious illness 2Health News:Haemacure Reports on its annual general and special meeting of shareholders 2Health News:Haemacure Reports on its annual general and special meeting of shareholders 3Health News:Haemacure Reports on its annual general and special meeting of shareholders 4Health News:Landmark Study Aims to Improve Osteoporosis Care Standards Worldwide 2Health News:Landmark Study Aims to Improve Osteoporosis Care Standards Worldwide 3Health News:RF Technologies Assists Healthcare Providers in Avoiding Preventable Injury Conditions to be Denied Reimbursement by Medicare 2
Indications For Usage: ,Adult (recommended tidal volume >150ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to ...
Indications For Usage: ,Pediatric (recommended tidal volume 70-250ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intend...
... Thermovent® T helps provide protection to the exposed ... and extremely lightweight making it ideal for active ... high rate of heat and moisture recovery, it ... ,All HMEs and filters have ISO standard tapered ...
... Since 1991 Intersurgical ... breathing filters, heat and ... oxygen therapy products, hand-held ... range of accessories and ...
Medicine Products: